This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Amid an ongoing patent dispute with Digene, Third Wave Technologies officials said last week that the firm is on track to submit its human papillomavirus diagnostic to the US Food and Drug Administration this year and expects to receive US clearance of its cystic fibrosis test in the third quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.